Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
78
LNMG Quote, Financials, Valuation and Earnings
Last price:
$0.0350
Seasonality move
:
614.68%
Day range:
$0.0350 - $0.0350
52-week range:
$0.0028 - $0.0619
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.95x
P/B ratio:
0.00x
Volume:
5K
Avg. volume:
5.3K
1-year change:
-43.46%
Market cap:
$121.6K
Revenue:
$13M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Linike Medical Group Ltd. has 98674.37% upside to fair value with a price target of -- per share.
LNMG vs. S&P 500
-
Over the past 5 trading days, Linike Medical Group Ltd. has overperformed the S&P 500 by 37.06% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Linike Medical Group Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Linike Medical Group Ltd. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Linike Medical Group Ltd. reported revenues of --.
Earnings Growth
-
Linike Medical Group Ltd. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Linike Medical Group Ltd. reported earnings per share of --.
Enterprise value:
18M
EV / Invested capital:
--
Price / LTM sales:
1.95x
EV / EBIT:
12.78x
EV / Revenue:
1.50x
PEG ratio (5yr expected):
3.33x
EV / Free cash flow:
-12.22x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
11.76x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $3.2M | $10.4M | $12M | $4.6M | $3.6M | |
| Gross Profit | $2.9M | $8.4M | $10.4M | $4.5M | $3.4M | |
| Operating Income | $349.9K | $1.3M | $1.4M | $711.6K | $2.4M | |
| EBITDA | $700K | $1.2M | $1.5M | $806.6K | $2.5M | |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2K | $4.9K | $25.2M | $26.9M | $29.1M | |
| Total Assets | $1.2K | $4.9K | $52.7M | $54M | $57.7M | |
| Current Liabilities | $32.7K | $68.3K | $6.5M | $6.5M | $8.5M | |
| Total Liabilities | $32.7K | $68.3K | $18.2M | $18.2M | $20.4M | |
| Total Equity | -$31.6K | -$63.4K | $34.5M | $35.9M | $37.3M | |
| Total Debt | -- | -- | $11.7M | $11.7M | $11.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $357.2K | -$2.9M | -$998.9K | -$261.2K | -$493.6K | |
| Cash From Investing | -- | -$59.7K | -$474.6K | -$900 | -$247.4K | |
| Cash From Financing | $357.8K | $2.4M | $172.4K | $718.2K | $270.5K | |
| Free Cash Flow | $357.2K | -$3M | -$1.5M | -$262.1K | -$741K | |
LNMG
Sector
Market Cap
$121.6K
--
Price % of 52-Week High
56.54%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-43.46%
--
Beta (5-Year)
-6.348
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.0269
200-day SMA
Buy
Level
$0.0155
Bollinger Bands (100)
Buy
Level
0.0094 - 0.0294
Chaikin Money Flow
Sell
Level
-3.2M
20-day SMA
Buy
Level
$0.0274
Relative Strength Index (RSI14)
Buy
Level
77.8903
ADX Line
Buy
Level
18.1869
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$0.0221
MACD (12, 26)
Buy
Level
0.0018
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-2.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6736)
Buy
CA Score
(Annual)
Level (0.2257)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (1)
Buy
Ohlson Score
Level (-1.9668)
Sell
Piotroski F Score
(Annual)
Level (2)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Linike Medical Group Ltd. is currently looking for new business operations. The company was founded on March 11, 2011 and is headquartered in Chengdu, China.
Stock Forecast FAQ
In the current month, LNMG has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LNMG average analyst price target in the past 3 months is --.
-
Where Will Linike Medical Group Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Linike Medical Group Ltd. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Linike Medical Group Ltd.?
Analysts are divided on their view about Linike Medical Group Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Linike Medical Group Ltd. is a Sell and believe this share price will drop from its current level to --.
-
What Is Linike Medical Group Ltd.'s Price Target?
The price target for Linike Medical Group Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LNMG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Linike Medical Group Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LNMG?
You can purchase shares of Linike Medical Group Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Linike Medical Group Ltd. shares.
-
What Is The Linike Medical Group Ltd. Share Price Today?
Linike Medical Group Ltd. was last trading at $0.0350 per share. This represents the most recent stock quote for Linike Medical Group Ltd.. Yesterday, Linike Medical Group Ltd. closed at $0.0350 per share.
-
How To Buy Linike Medical Group Ltd. Stock Online?
In order to purchase Linike Medical Group Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LNMG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LNMG
Sector
P/E ratio
--
--
PEG ratio
3.33x
--
P/B ratio
0.00x
--
Price / LTM sales
1.95x
--
Growth Metrics
LNMG
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
LNMG
Sector
Profitability FY 2024
$13M
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Mar
3
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Jun
2
Balance Sheet
LNMG
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$55.6M
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Mar 2
Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.
Buy
90
BNAI alert for Mar 2
Brand Engagement Network, Inc. [BNAI] is up 2.44% over the past day.
Sell
36
WLDN alert for Mar 2
Willdan Group, Inc. [WLDN] is down 1.93% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
